Altimmune Inc (GB:0A4C)

Altimmune (0A4C) Financial Statements


Altimmune Financial Overview

Altimmune's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Altimmune is scheduled to report earnings on August 15, 2023, and the estimated EPS forecast is $-0.47. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 21.00K$ -110.00K$ 2.00K$ 8.00K$ 32.00K
Gross Profit$ 21.00K$ -110.00K---
EBIT$ -21.74M$ -23.31M$ -23.65M$ -20.04M$ -19.37M
EBITDA$ -21.74M$ -23.34M$ -23.65M$ -19.99M$ -19.25M
Net Income Common Stockholders$ -20.07M$ -21.66M$ -23.52M$ -20.11M$ -19.43M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 165.76M$ 184.91M$ 201.83M$ 184.76M$ 179.95M
Total Assets$ 187.08M$ 206.93M$ 225.28M$ 209.91M$ 205.66M
Total Debt$ 4.40M$ 4.58M$ 1.23M$ 1.33M$ 1.44M
Net Debt$ -161.36M$ -180.33M$ -200.60M$ -183.42M$ -178.51M
Total Liabilities$ 19.35M$ 21.64M$ 20.25M$ 15.37M$ 20.79M
Stockholders Equity$ 167.73M$ 185.29M$ 205.03M$ 194.53M$ 184.87M
Cash Flow-
Free Cash Flow$ -19.46M$ -17.34M$ -15.11M$ -16.72M$ -13.54M
Operating Cash Flow$ -19.41M$ -17.31M$ -15.05M$ -16.70M$ -13.53M
Investing Cash Flow$ 13.30M$ 981.00K$ -25.40M$ -48.97M$ -9.00K
Financing Cash Flow$ -302.00K$ -43.00K$ 32.06M$ 21.58M$ 3.18M
Currency in USD

Altimmune Earnings and Revenue History

Altimmune Debt to Assets

Altimmune Cash Flow

Altimmune Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis